Olatoyosi Odenike to Bridged Bicyclo Compounds, Heterocyclic
This is a "connection" page, showing publications Olatoyosi Odenike has written about Bridged Bicyclo Compounds, Heterocyclic.
Connection Strength
0.267
-
Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy. Leuk Lymphoma. 2024 Jun; 65(6):864-867.
Score: 0.221
-
A phase 1 study of the pan-bromodomain and extraterminal inhibitor mivebresib (ABBV-075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia. Cancer. 2021 08 15; 127(16):2943-2953.
Score: 0.045